SCHEMBL290688

SCHEMBL290688

CCC[CH]C(O)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289814 0.86
SCHEMBL15846758 0.83 KMT2A (0.41)
SCHEMBL28300366 0.81 ACHE (0.42)
SCHEMBL7948617 0.81 TSHR (0.44)
SCHEMBL28193263 0.81 TSHR (0.44)
SCHEMBL5685729 0.81 TSHR (0.44)
SCHEMBL9943700 0.80
SCHEMBL1717785 0.80
SCHEMBL6434555 0.80
SCHEMBL3386161 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054591-A1 AGROCHEMICAL GEL COMPOSITIONS MONSANTO TECHNOLOGY LLC 2023-02-23 US claimed
US-20200254041-A1 RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS RECEPTOR HOLDINGS, INC. (US) 2020-08-13 US claimed
EP-3672610-A1 RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS Receptor Holdings, Inc. (US) 2020-07-01 EP claimed
WO-2019071213-A1 RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS RECEPTOR LIFE SCIENCES, INC. (US) 2019-04-11 WO claimed
EP-2427172-B1 A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS ALLERGAN SALES LLC (US) 2017-11-01 EP claimed
EP-1565136-B1 COMPOSITIONS FOR TRANSDERMAL OXYBUTYNIN THERAPY WATSON PHARMACEUTICALS INC (US) 2015-02-25 EP claimed
EP-2612629-A1 Compositions for transdermal oxybutynin therapy Watson Pharmaceuticals, Inc. (US) 2013-07-10 EP claimed
EP-2544532-A2 AGROCHEMICAL GEL COMPOSITIONS Monsanto Technology LLC (US) 2013-01-16 EP claimed
US-8241662-B2 Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy WATSON LABORATORIES, INC. (US) 2012-08-14 US claimed
WO-2011113061-A2 AGROCHEMICAL GEL COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2011-09-15 WO claimed
US-20240009151-A1 FORMULATIONS OF AZOBENZENE PHOTOREACTIVE COMPOUNDS BAYON THERAPEUTICS, INC. 2024-01-11 US disclosed
US-20230357451-A1 ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME CYDEX PHARMACEUTICALS INC (US) 2023-11-09 US disclosed
US-11795241-B2 Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same CYDEX PHARMACEUTICALS, INC. (US) 2023-10-24 US disclosed
EP-3183295-B1 FRACTIONATED ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME CYDEX PHARMACEUTICALS INC (US) 2023-08-02 EP disclosed
US-11707451-B2 Pharmaceutical composition for modified release ASTELLAS PHARMA INC. (JP) 2023-07-25 US disclosed
US-20030147926-A1 Compositions and methods for transdermal oxybutynin therapy WATSON PHARMACEUTICALS, INC. 2003-08-07 US disclosed
CN-1307502-A Ultraviolet irradiation device for photochemical reaction and method for producing vitamin D derivative using same CHUGAI PHARMACEUTICAL CO LTD (JP) 2001-08-08 CN disclosed
EP-1103300-A1 ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-05-30 EP disclosed
US-4285987-A Process for manufacturing device with dispersion zone ALZA CORPORATION (US) 1981-08-25 US disclosed
US-4200098-A Osmotic system with distribution zone for dispensing beneficial agent ALZA CORPORATION (US) 1980-04-29 US disclosed